Literature DB >> 23148746

Dendritic cells: an immunotherapy coming of age.

David F Stroncek1, Francisco M Marincola.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23148746      PMCID： PMC3501988          DOI： 10.2217/imt.12.102

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  9 in total

1.  B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.

Authors:  James N Kochenderfer; Mark E Dudley; Steven A Feldman; Wyndham H Wilson; David E Spaner; Irina Maric; Maryalice Stetler-Stevenson; Giao Q Phan; Marybeth S Hughes; Richard M Sherry; James C Yang; Udai S Kammula; Laura Devillier; Robert Carpenter; Debbie-Ann N Nathan; Richard A Morgan; Carolyn Laurencot; Steven A Rosenberg
Journal:  Blood       Date:  2011-12-08       Impact factor: 22.113

2.  Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.

Authors:  Steven A Rosenberg; James C Yang; Richard M Sherry; Udai S Kammula; Marybeth S Hughes; Giao Q Phan; Deborah E Citrin; Nicholas P Restifo; Paul F Robbins; John R Wunderlich; Kathleen E Morton; Carolyn M Laurencot; Seth M Steinberg; Donald E White; Mark E Dudley
Journal:  Clin Cancer Res       Date:  2011-04-15       Impact factor: 12.531

3.  Prolonged antitumor NK cell reactivity elicited by CXCL10-expressing dendritic cells licensed by CD40L+ CD4+ memory T cells.

Authors:  Kanako Shimizu; Miki Asakura; Shin-ichiro Fujii
Journal:  J Immunol       Date:  2011-04-01       Impact factor: 5.422

4.  Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment.

Authors:  Jianjian Jin; Marianna Sabatino; Robert Somerville; John R Wilson; Mark E Dudley; David F Stroncek; Steven A Rosenberg
Journal:  J Immunother       Date:  2012-04       Impact factor: 4.456

5.  Quality controls in cellular immunotherapies: rapid assessment of clinical grade dendritic cells by gene expression profiling.

Authors:  Luciano Castiello; Marianna Sabatino; Yingdong Zhao; Barbara Tumaini; Jiaqiang Ren; Jin Ping; Ena Wang; Lauren V Wood; Francesco M Marincola; Raj K Puri; David F Stroncek
Journal:  Mol Ther       Date:  2012-11-13       Impact factor: 11.454

Review 6.  Engineering dendritic cells to enhance cancer immunotherapy.

Authors:  Jeanette E Boudreau; Aude Bonehill; Kris Thielemans; Yonghong Wan
Journal:  Mol Ther       Date:  2011-04-05       Impact factor: 11.454

7.  15 kDa granulysin causes differentiation of monocytes to dendritic cells but lacks cytotoxic activity.

Authors:  Carol Clayberger; Michael W Finn; Tianhong Wang; Reena Saini; Christine Wilson; Valarie A Barr; Marianna Sabatino; Luciano Castiello; David Stroncek; Alan M Krensky
Journal:  J Immunol       Date:  2012-05-14       Impact factor: 5.422

8.  New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer.

Authors:  David F Stroncek; Carolina Berger; Martin A Cheever; Richard W Childs; Mark E Dudley; Peter Flynn; Luca Gattinoni; James R Heath; Michael Kalos; Francesco M Marincola; Jeffrey S Miller; Gustavo Mostoslavsky; Daniel J Powell; Mahendra Rao; Nicholas P Restifo; Steven A Rosenberg; John O'Shea; Cornelis J M Melief
Journal:  J Transl Med       Date:  2012-03-15       Impact factor: 5.531

9.  15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level.

Authors:  Luciano Castiello; David F Stroncek; Michael W Finn; Ena Wang; Francesco M Marincola; Carol Clayberger; Alan M Krensky; Marianna Sabatino
Journal:  J Transl Med       Date:  2011-04-18       Impact factor: 5.531
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.